To highlight our findings concerning the regulation of TRIP6 expression in sensitive and taxane-resistant MCF-7 breast cancer cell lines, we evaluated TRIP6 mRNA expression against clinical data of breast cancer patients who had undergone taxane-containing regimens. The gene discussed is TRIP6; the disease is breast carcinoma.